Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > 291,882,711
View:
Post by thedave2006 on Oct 30, 2015 3:41pm

291,882,711

all the best.....have a good weekend.
Comment by ragingbull1327 on Oct 30, 2015 4:03pm
That must be how many hours it's taken them to get to this point since discovering the treatment.  
Comment by ragingbull1327 on Oct 30, 2015 4:06pm
Never mind.   It only FEELS like it's taken them 335 years.   Pffft.    Slow pokes.   Its more likely to be the amount of shares outstanding.   Which is even more incredible, actually.    At the end of the day, these people have essentially accomplished as much as Slasher Pam.   Nothing
Comment by ragingbull1327 on Oct 30, 2015 4:30pm
Sorry.   335 years.   Times 100
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities